Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
22.2M
-
Number of holders
-
453
-
Total 13F shares, excl. options
-
17.8M
-
Shares change
-
-556K
-
Total reported value, excl. options
-
$6.76B
-
Value change
-
-$278M
-
Put/Call ratio
-
1.74
-
Number of buys
-
196
-
Number of sells
-
-271
-
Price
-
$379.12
Significant Holders of BIO-RAD LABORATORIES, INC. - Common (BIO) as of Q2 2023
555 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Common as of Q2 2023.
BIO-RAD LABORATORIES, INC. - Common (BIO) has 453 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.8M shares
of 22.2M outstanding shares and own 80.36% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (2.4M shares), BlackRock Inc. (1.58M shares), Veritas Asset Management LLP (1.14M shares), BROWN ADVISORY INC (927K shares), STATE STREET CORP (901K shares), ALLIANCEBERNSTEIN L.P. (459K shares), GEODE CAPITAL MANAGEMENT, LLC (451K shares), BANK OF AMERICA CORP /DE/ (447K shares), WESTFIELD CAPITAL MANAGEMENT CO LP (404K shares), and SOUTHEASTERN ASSET MANAGEMENT INC/TN/ (326K shares).
This table shows the top 453 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.